FDA Inspection 1113155 — Fred Hutchinson Cancer Center (FHCC)
The FDA completed an inspection of Fred Hutchinson Cancer Center (FHCC) on November 20, 2019 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 20, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Seattle, WA (United States)